Aktienanalyse zu Cigna Group (CI)CICigna Group

The Cigna Group is a global health company. The Company has two segments: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to customers and clients. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, as well as clinical programs to help the clients. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Cigna Group's current price is $278.88, with a forward P/E of 9.25, suggesting it is undervalued compared to the market. However, insider selling has increased by 4982.25%, indicating potential concerns about the company's future. Analysts have downgraded their ratings, with Jefferies lowering its target from $336 to $307, reflecting a cautious outlook. Given these factors, it may be wise to hold rather than buy at this time.

17 analysts cover CI: 13 rate it Buy, 4 Hold and 0 Sell. The average price target is 335.63.